Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.
Investor's Business Daily on MSN
Biotech stock nears entry after FDA news; earnings on horizon
Krystal Biotech is engaged in developing genetic medicines. The biotech stock is near a buy point with earnings due soon.
Biotech-based exchange-traded fund (“ETF”) iShares Biotechnology ETF IBB rallied 30.2% over the past six months (as of Oct. 15, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 26.5%). Year to date ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results